Certara participated in the pretomanid development program providing scientific support to the TB Alliance and the Bill & Melinda Gates Foundation.Read More
Author: David Salinger, Ellen Leinfuss
David is a Director of Consulting Services at Certara Strategic Consulting. He joined Certara in October, 2015 after spending seven years at Amgen, where he served as both scientific director, quantitative pharmacology and principal scientist, quantitative pharmacology. Prior to joining the pharmaceutical industry, David served as a research scientist for population kinetics in the department of bioengineering and the University of Washington. Additionally, he served as a research consultant at Columbia Basin Research, where he was responsible for the development and implementation of algorithms for data analysis, modeling and simulation of salmon migrations. He obtained his PhD at the University of Washington and Masters of Science from Penn State. As trusted advisor to the CEO and Senior Leadership team, the Chief Corporate Affairs Officer provides input and feedback on strategy, communication, and reputation. In this capacity, Ms. Leinfuss is responsible for developing the company brand and “go to market” strategy for the company’s many technology-based products and consulting solutions. Providing strategic guidance to the company’s North American, European, and Asian sales ecosystem, she analyzes market opportunities, creates new products and solutions, and develops commercial programs. She serves as the key spokesperson for the company. Ms. Leinfuss brings more than 30 years of experience leading marketing, business development, and sales management groups for technical and scientific-based organizations. Prior to joining Certara, she served as SVP and Head of Life Sciences at UL EduNeering, a global provider of regulatory compliance educational solutions, delivered via cloud-based technology. At UL, Leinfuss directed the strategic development of the company’s solutions to the life science market, including pharmaceutical, medical device, biologics, clinical, and managed care health plans. In addition, she managed the company’s strategic alliances, including the company’s 15 year Cooperative Research and Development Agreement (CRADA) with the US FDA and its exclusive partnerships with AdvaMed and the Personal Care Products Council, among others. Leinfuss possesses an MBA in marketing from the City University of New York and a BS in chemistry from the State University of New York.